RxSight ($RXST) Sales Execution Failures, Guidance Cut, and Executive Turnover Case

The court has appointed the lead plaintiff to represent the class.

C.D. California

Court

8:25-cv-01596

Case number

11/07/2024

Class period Start

07/08/2025

Class period End

09/22/2025

Lead Plaintiff motion deadline

$RXST investors filed a claim against RxSight for overstating demand for its intraocular lens system, misrepresenting its sales execution, and concealing internal challenges that led to poor financial results and the abrupt resignation of its CFO.
After missing revenue expectations, slashing full-year guidance, and announcing the departure of CFO Bret Schneider, $RXST fell a combined 58.5%, including 32.5% on July 15, 2025, and 26% on July 16, 2025.
$RXST investors can join this case to be notified about potential recovery.
Case Details:

Between March 15, 2024, and July 15, 2025, RxSight promoted rapid commercial momentum for its Light Adjustable Lens (LAL) platform. Executives repeatedly stated that the company was “well-positioned for continued growth,” citing strong demand and reliable execution.

In reality, RxSight was struggling with channel saturation, poor sales productivity, and declining efficiency across its customer base. Internal projections showed a slowdown, but management continued to issue bullish public guidance.

On July 15, 2025, the company reported Q2 2025 results that badly missed expectations. RxSight slashed full-year revenue guidance by over $25 million and announced the immediate resignation of CFO Bret Schneider. $RXST dropped 32.5% that day and another 26% on July 16.

Based on these events, $RXST investors filed a claim against the company, alleging it:
It misled investors about the sustainability of demand and market adoption.
It concealed deteriorating sales execution and customer productivity issues.
It withheld material risks tied to its financial outlook and executive stability.
Investors believe RxSight inflated its growth narrative to maintain valuation while internal challenges mounted.

Case Type

US Securities Class Action

Case Status

Lead Plaintiff Appointed

Alleged Offence

Misleading Statements,

Financial Misrepresentation,

Failure to Disclose

Suspected Party

Directors,

Management

Security Type

Stocks

Trade Direction

Long

Shock Event Date

05/08/2025

Filing date

07/22/2025

Lead Plaintiff Deadline

09/22/2025

Trusted by industry leaders

Endorsed by top professionals who trust our innovative solutions to drive impactful results.